Total Payments
$12,729
2024 Payments
$980.61
Companies
31
Transactions
104
Medicare Patients
1,499
Medicare Billing
$110,104
Payment Breakdown by Category
Consulting$6,464 (50.8%)
Travel$2,278 (17.9%)
Food & Beverage$2,257 (17.7%)
Education$1,028 (8.1%)
Other$702.14 (5.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,464 | 4 | 50.8% |
| Travel and Lodging | $2,278 | 9 | 17.9% |
| Food and Beverage | $2,257 | 83 | 17.7% |
| Education | $1,028 | 7 | 8.1% |
| Debt forgiveness | $702.14 | 1 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $4,652 | 3 | $0 (2023) |
| Intuitive Surgical, Inc. | $2,842 | 9 | $0 (2020) |
| AstraZeneca UK Limited | $1,074 | 1 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $757.50 | 1 | $0 (2021) |
| Olympus America Inc. | $717.35 | 2 | $0 (2024) |
| PFIZER INC. | $397.77 | 20 | $0 (2024) |
| Coloplast Corp | $379.95 | 5 | $0 (2018) |
| Endocare, Inc. | $369.79 | 3 | $0 (2017) |
| Janssen Biotech, Inc. | $189.60 | 11 | $0 (2024) |
| Photocure Inc | $187.37 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $980.61 | 16 | Olympus America Inc. ($702.14) |
| 2023 | $3,058 | 11 | Merck Sharp & Dohme LLC ($2,725) |
| 2022 | $2,047 | 8 | Merck Sharp & Dohme LLC ($1,927) |
| 2021 | $987.94 | 10 | Janssen Scientific Affairs, LLC ($757.50) |
| 2020 | $2,363 | 12 | Intuitive Surgical, Inc. ($1,127) |
| 2019 | $2,082 | 16 | Intuitive Surgical, Inc. ($1,716) |
| 2018 | $279.57 | 12 | Janssen Products, LP ($74.99) |
| 2017 | $932.17 | 19 | Endocare, Inc. ($369.79) |
All Payment Transactions
104 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 10/02/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Immunology | ||||||
| 09/26/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $25.35 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/04/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.38 | General |
| Category: Immunology | ||||||
| 08/21/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: Diagnostic Imaging | ||||||
| 08/07/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: Immunology | ||||||
| 07/10/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Immunology | ||||||
| 06/05/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Immunology | ||||||
| 05/30/2024 | Olympus America Inc. | — | Debt forgiveness | In-kind items and services | $702.14 | General |
| 05/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Immunology | ||||||
| 04/24/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $23.23 | General |
| Category: ONCOLOGY | ||||||
| 02/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $14.28 | General |
| Category: ONCOLOGY | ||||||
| 02/07/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ONCOLOGY | ||||||
| 11/01/2023 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Urology | ||||||
| 09/25/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $2,725.00 | General |
| 06/21/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ONCOLOGY | ||||||
| 06/08/2023 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/03/2023 | PALETTE LIFE SCIENCES, INC. | — | Food and Beverage | In-kind items and services | $166.42 | General |
| 05/03/2023 | Aurinia Pharma U.S., Inc. | LUPKYNIS (Drug) | Food and Beverage | In-kind items and services | $16.14 | General |
| Category: LUPUS NEPHRITIS | ||||||
| 04/20/2023 | AbbVie Inc. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/30/2023 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $17.30 | General |
| Category: HORMONE THERAPY | ||||||
| 03/15/2023 | PFIZER INC. | XTANDI (Drug), ORGOVYX, PAXLOVID | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 306 | 400 | $88,229 | $26,126 |
| 2022 | 6 | 313 | 384 | $85,610 | $23,708 |
| 2021 | 11 | 428 | 536 | $109,691 | $31,557 |
| 2020 | 10 | 452 | 553 | $148,940 | $28,713 |
Total Patients
1,499
Total Services
1,873
Medicare Billing
$110,104
Procedure Codes
52
All Medicare Procedures & Services
52 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 68 | 95 | $21,470 | $7,758 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 38 | 61 | $13,786 | $4,386 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 59 | $9,204 | $3,308 | 35.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 21 | 30 | $13,170 | $2,833 | 21.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 35 | 48 | $7,488 | $2,379 | 31.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 14 | 23 | $10,097 | $1,447 | 14.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 13 | 13 | $3,783 | $1,378 | 36.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,784 | $1,118 | 29.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 11 | 11 | $3,784 | $1,092 | 28.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2023 | 14 | 15 | $1,425 | $318.01 | 22.3% |
| 81002 | Urinalysis, manual test | Office | 2023 | 31 | 34 | $238.00 | $109.80 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 51 | 65 | $14,690 | $5,267 | 35.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 46 | 59 | $13,334 | $4,157 | 31.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 49 | 59 | $9,204 | $3,113 | 33.8% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2022 | 25 | 34 | $14,926 | $2,848 | 19.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 32 | 42 | $6,621 | $2,032 | 30.7% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2022 | 23 | 28 | $12,292 | $1,853 | 15.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 16 | 16 | $5,504 | $1,780 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 16 | 16 | $5,504 | $1,529 | 27.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 16 | 19 | $1,805 | $573.95 | 31.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Facility | 2022 | 14 | 16 | $1,520 | $452.45 | 29.8% |
| 81002 | Urinalysis, manual test | Office | 2022 | 25 | 30 | $210.00 | $102.85 | 49.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 67 | $15,142 | $5,484 | 36.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 44 | 54 | $12,204 | $4,165 | 34.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 58 | 78 | $12,168 | $3,915 | 32.2% |
About Dr. Michael Cher, MD
Dr. Michael Cher, MD is a Urology healthcare provider based in Detroit, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1336187400.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Cher, MD has received a total of $12,729 in payments from pharmaceutical and medical device companies, with $980.61 received in 2024. These payments were reported across 104 transactions from 31 companies. The most common payment nature is "Consulting Fee" ($6,464).
As a Medicare-enrolled provider, Cher has provided services to 1,499 Medicare beneficiaries, totaling 1,873 services with total Medicare billing of $110,104. Data is available for 4 years (2020–2023), covering 52 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Location Detroit, MI
- Active Since 06/02/2006
- Last Updated 10/25/2016
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1336187400
Products in Payments
- Da Vinci Surgical System (Device) $2,842
- XTANDI (Drug) $466.92
- Endocare Cryocare System (Medical Supply) $369.79
- PENILE RECONSTRUCTION (Device) $336.19
- Cysview (Drug) $187.37
- AMS (Device) $162.80
- TREMFYA (Drug) $158.21
- ZYTIGA (Drug) $103.11
- Axumin (Drug) $65.90
- ORGOVYX (Drug) $61.53
- LUPRON DEPOT (Drug) $50.99
- Xofigo (Drug) $49.55
- PROVENGE (Drug) $48.37
- TOVIAZ (Drug) $45.33
- SUTENT (Drug) $37.53
- ADSTILADRIN (Biological) $37.51
- LigaSure (Device) $35.62
- CONTINENCE CARE (Device) $25.30
- rezum Generator (Device) $24.16
- GEMTESA (Drug) $23.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Detroit
Aram Loeb, M.d, M.D
Urology — Payments: $112,827
Urology $112,827
David Leavitt
Urology — Payments: $58,845
Urology $58,845
Craig Rogers, M.d, M.D
Urology — Payments: $34,971
Urology $34,971
Amit Patel, Md, MD
Urology — Payments: $15,436
Urology $15,436
James Peabody, M.d, M.D
Urology — Payments: $10,604
Urology $10,604
Mani Menon, M.d, M.D
Urology — Payments: $9,013
Urology $9,013